Treatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patients whose options have been very limited up to now, according to French researchers reporting their phase III randomized study findings at the World Congress on …
sunitinib
 Mark Socinski |
 Bruce Johnson |
 Neil Shah |
 Doug Smith |
Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer
REFERENCE: Abstract 7001
Mark A. Socinski, Univerisity of North Carolina, Chapel Hill
The use of anti-angiogenic therapy for treating patients with non-small cell
…